GRYO .0007 HUGE NEWS All Content and Data provided by

New Post Public Reply Private Reply Replies (0) Message Board
FLA
GRYO .0007 HUGE NEWS


All Content and Data provided by Third-Parties — Terms of Use
Nonprofit to Rescue 'Languishing' Georgia Proton Beam Center
SOURCEMEDIA 7:03 PM ET 12/14/2016
Symbol Last Price Change
GRYO 0.0007down 0 (0%)
QUOTES AS OF 10:29:27 AM ET 12/15/2016
BRADENTON, Fla. – A nonprofit group plans to rescue a distressed commercial proton beam therapy venture in Atlanta, and turn its operation over to Georgia's only National Cancer Institute-designated center.

The Atlanta Development Authority has given preliminary approval to serve as the conduit issuer for up to $400 million of senior and subordinate bonds to finish and equip the 170,000-square-foot, three-story building near Emory University Healthcare in midtown where the advanced radiation treatment for cancer will be offered.

The facility will be financed and owned by Provident Resources Group Inc., a national nonprofit asset development and management firm with corporate headquarters in Baton Rouge, La.

"This is a project that has languished in midtown Atlanta for several years and is now being brought back to life," said Steve E. Hicks, Provident Resources' chairman and chief executive officer. "It will be completed."

Emory and the NCI-designated Winship Cancer Institute will be the clinical partners operating the Proton Therapy Center to treat adult and pediatric cancer with proton beam technology, which allows a more targeted attack on cancers than traditional radiation treatment.

For Hicks, who is also a former bond lawyer, investing in the Atlanta facility culminates a decade in which he developed a "passion" for proton beam technology, learning about it after working on two prior projects that failed to materialize.

He's also had a number of friends, including a bond attorney, who were treated successfully at other proton beam centers and helped convince him that Provident should be involved.

"What's so amazing about proton therapy in treating children is that the use of the proton beam does not damage any surrounding organs and tissue in a developing young child," he said.

Proton beam therapy, he added, is also effective in the treatment of prostate cancer in men and breast cancer in women, particularly left breast cancer because it limits the risk of damage to the heart.

The Atlanta project has been in the works for several years.

In May 2013, groundbreaking took place on the original Georgia Proton Treatment Center, which Emory and Winship Cancer Institute also planned to participate in.

At the time, they said the project would herald the arrival to Georgia of the "most advanced radiation therapy" in the United States.

"Proton beam therapy allows for more precise treatment of a tumor," Emory Healthcare said in an announcement then. "The most important benefit to proton beam therapy is that it limits damage to nearby tissue more than other radiation therapies currently available."

Emory and the Winship planned to treat patients and conduct clinical trials "to better understand the best uses for this advanced form of radiation treatment."

The Georgia Proton Treatment Center and three other centers in various locations were being developed by California-based Advanced Particle Therapy.

APT later encountered funding difficulties.

Three creditors from Texas filed an involuntary Chapter 11 bankruptcy petition against Georgia Proton Treatment Holdings LLC in the U.S. Bankruptcy Court for the District of Delaware on March 4, 2016, according to court records.

The creditors - Zeitgeist Capital LLC, Gryphon Resources Inc.(GRYO), and Cobalt LLC - said they lent $8.28 million to the debtor.

However, the bankruptcy case didn't go far.

On April 15, the creditors filed a joint motion to dismiss the case because Georgia Proton Treatment Holdings was "in the process of negotiating permanent financing" to open the Atlanta center and increase their recoveries.

Due to confidentiality agreements, no details about the permanent financing were presented to the bankruptcy court. Judge Kevin Gross dismissed the case on May 9.

Hicks said a group of investors in the Georgia Proton Treatment Center removed Advanced Particle Therapy from the transaction, and reached out to Provident Resources Group in an effort to complete the project with a nonprofit entity, instead of the original for-profit commercial venture.

"The investors we are dealing with are not the investors that tried to put the project into bankruptcy," he said. "We're working very well with them and we're acquiring the assets they have invested in. Our goal is to make them whole and complete the project so it can service the entire great Atlanta market."

Hicks said he is also working on developing a proton therapy center in south Louisiana and three other locations around the country that he cannot disclose due to confidentiality agreements.

"Nothing would make me happier for Provident than to bring a proton therapy treatment center to greater Baton Rouge and the south Louisiana market," which would also serve Mississippi, Alabama, and the northwest panhandle of Florida, he said.

Hicks said the proton centers are the "exciting" projects he wanted to do after practicing as a bond lawyer for 25 years.

He started the nonprofit Provident Resources Group in 1999.

It has 32 employees who manage assets in 18 states and the District of Columbia in the higher education, healthcare, housing, senior living, and state and local government sectors.

"We've done over $2 billion in projects around the country," Hicks said. "I also have the opportunity to work on some amazing projects like proton therapy and very challenging higher education projects around the country."

As a Louisiana State University graduate, Hicks said he was "very proud" of Provident's recent involvement with LSU's $575 millionNicholson Gateway Project.

Some $476 million of bonds were sold in several series by the Louisiana Public Facilities Authority.

The deal, LSU's largest privatization undertaking, closed in October.

Provident is the nonprofit borrower for the LSU project, which includes building 1,531 beds in seven on-campus residence halls, a 10,000-square-foot recreation facility, 38,000 square feet of retail space, and 1,625 parking spaces.

The firm's most recent project was a public-private partnership with the University of Massachusetts Boston to develop a 1,082 bed student housing facility and a dining facility.

The Massachusetts Development Finance Agency issued $130 million of revenue bonds for the Provident-UMass project, which closed in early November.

Hicks said endeavors, such as the Georgia proton beam project, are rewarding.

"When you have a chance to work on a project like this, and you know it will impact in a large market area, it's exciting," he said. "It's a lot of fun being involved and to see it materialize."

The Atlanta Development Authority is expected to give final approval to the deal at its Feb. 16 meeting, according to spokesman Matt Fogt.

Citi, senior manager for the financing, will determine the ultimate size of the bond issue and date of pricing.

However, Hicks said that his agency is targeting a $325 million to $350 million deal using an as-yet undetermined combination of tax-exempt and taxable bonds.

Closing is expected April 1.

Bond proceeds will be used to finish the Atlanta proton treatment center, construct a 165-space parking deck with about 4,000 square feet of ground-level retail space, provide start-up working capital, and acquire the "ownership interest" of the current investors.

Because of the construction risk related to completion of the facility, it has not been determined whether ratings will be obtained.

"We're very proud to be associated with an institution that is internationally known like Emory, to have them as our clinical partner and to be able to serve a large region, not just greater Atlanta, but a large portion of the Southeast," he said.

Piedmont Securities LLC is the structuring agent for Provident Resources Group and Georgia Proton Treatment Center.

Bond counsel is Butler Snow LLP.

Underwriters' counsel is Nixon Peabody LLP.

Fishman Haygood LLP and Holland & Knight are Provident's legal team.

(c) 2016 The Bond Buyer. All rights Reserved.
I ONLY POST WHAT I PLAY
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Rutter Mills Expands Turkey Giveaway to Two Cities

Updated Category News Views 78

An Extra Helping of Community Spirit Rutter Mills is back on the scene again this Thanksgiving, slinging out a thousand turkeys to show their appreciation for the community they’ve called home since 1959. This initiative is the second iteration of their Turkey Drop, an event that's set to become a cherished tradition for years to come. Last year's event only teased the...

Continue Reading
James Hardie Joins S&P MidCap 400; Roku Acquired

Updated Category News Views 97

A Shift in the MidCap 400: What's Up? Well, wouldn’t you know it, James Hardie Industries is making waves as it steps into the S&P MidCap 400. This move happens because Fox Corp. has nabbed Roku in a deal worthy of some popcorn. Come November 11, when the trading floor wakes up, James Hardie will be in and Roku will be out. Pretty neat switcheroo if you ask me. Inside...

Continue Reading
Off-Broadway Play 'DUST' Raises Autism Support Funds

Updated Category News Views 185

Here's the scoop: an Off-Broadway production just did something many big hitters can't pull off. 'DUST,' a show crafted like a love letter to the American West, managed to rustle up $30,000 for young adults grappled with autism. Partnering with no less than Yale's Cultural Autism Studies and the Ed Asner Family Center, this effort hit the mark in more ways than one. An...

Continue Reading
Aurora Innovation Faces Legal Heat Amid Delays

Updated Category News Views 76

Production Snags at Aurora Innovation Ah, investing – not for the faint-hearted. One day you're riding high, the next you're scraping by, and Aurora Innovation's (NASDAQ:AUR) investors just hit a rough patch. The autonomous trucking darling announced unexpected delays in its delivery schedule, sending shockwaves through its stock price and shaking investor confidence....

Continue Reading
Koppers Faces Investigation: Investors Cautious Amid Probe

Updated Category News Views 194

Deep Dive: Koppers' Financial Turmoil When a company throws a financial party, you don't expect the hangover to come in the form of an investigation notice. That’s what’s brewing over at Koppers Holdings Inc., leading many seasoned investors to take a hard, scrutinizing look at the books. The latest buzz? An inquiry into whether the company gave its investors the full...

Continue Reading
Evaluating GLP-1 Telehealth? Key Questions to Consider

Updated Category News Views 115

Navigating the Landscape of GLP-1 Telehealth Providers In the sprawling jungle of telehealth options for GLP-1 care, it's easy to feel like you're drowning in sameness. Picture this: you land on a sleek page promising the moon and stars, but who knows what's behind the curtain? That's where seasoned advice comes in, like a compass in this murky digital forest. Meant, a...

Continue Reading
Pinterest Faces Legal Probe: Investor Concerns Rise

Updated Category News Views 95

Legal Storms Gather on Pinterest's Horizon I remember a time when Pinterest was the darling of Wall Street, but here we are, staring at an investigation that's got more layers than an onion. On November 6, 2026, news broke that Kahn Swick & Foti, LLC (KSF) is sniffing around Pinterest's officers and directors. This is no small fry since KSF is steered by none other than...

Continue Reading
Tenax Sued: Investors Face Class Action Over TNX-103

Updated Category News Views 133

What Tenax Investors Need to Know Alright, folks, time to pull up a chair and pay attention to what's brewing with Tenax Therapeutics—yeah, we're talking NASDAQ: TENX. The company's head is spinning as it's caught up in a securities class action lawsuit. What's the fuss? The fine print here accuses Tenax of misleading investors about the effectiveness of their product,...

Continue Reading
Paris Baguette Pioneers Drive-Thru in Oklahoma

Updated Category News Views 108

Tapping The Unseen Potential In Bakery Cafes Every so often a business move comes along that makes you sit up and say, "Why the hell haven't they done this before?" Paris Baguette has finally cracked that code, rolling out its first-ever drive-thru in Moore, Oklahoma. Now, imagine yourself zipping through for a croissant without leaving the comfort of your car seat. Makes...

Continue Reading
Invasive Procedures Don't Extend Life in Stable Heart Disease

Updated Category News Views 157

Challenging Longstanding Beliefs Today’s news from the heart research front might set a few cardiology heads spinning. We’ve got big-time findings out of the ISCHEMIA-EXTEND study, throwing more weight on the evidence pile that early invasive heart procedures for patients with stable coronary artery disease don’t actually extend your life. Managing care with a blend...

Continue Reading

Top 5 Most Recently Viewed Articles

Alex Bastian Named VP of Commercial Strategy at Memo Therapeutics

Updated Category News Views 287

Alex Bastian Appointed as VP of Commercial Strategy at Memo Therapeutics AG Memo Therapeutics AG (or “MTx”), a late-stage biotech firm committed to transforming unique human immune responses into effective treatments for viral infections and cancer, has announced the appointment of Alex Bastian as its new VP of Commercial Strategy. Expertise in the Biotech Industry...

Continue Reading
AST SpaceMobile Partners with SDA to Advance Space Technology

Updated Category News Views 241

AST SpaceMobile's New Partnership with the Space Development Agency AST SpaceMobile, Inc. (NASDAQ: ASTS), a pioneering company in the development of the world's first space-based cellular broadband network, has made a significant stride by securing an initial contract with the Space Development Agency (SDA). This selection as a prime contractor represents a substantial...

Continue Reading
CIP Chemicals Market Set to Reach $3.69 Billion by 2029

Updated Category News Views 134

Exploring the Growth of the CIP Chemicals Market The CIP Chemicals Market is on an exciting trajectory, with projections indicating remarkable growth in the coming years. Analysts anticipate that the market will expand from USD 2.40 billion in 2024 to an impressive USD 3.69 billion by the year 2029. This growth signals a compound annual growth rate (CAGR) of 9.0%,...

Continue Reading
Rocket Lab Expands Partnership with iQPS for Future Missions

Updated Category News Views 217

Rocket Lab Partners with iQPS for Key Missions Rocket Lab USA, Inc. (Nasdaq: RKLB) has announced a significant contract with Institute for Q-shu Pioneers of Space, Inc. (iQPS), further solidifying its position as a leading provider of satellite launches. This new agreement includes three dedicated Electron missions, which will begin launching as early as 2026 from Rocket...

Continue Reading
Vinpai's Revenue and Growth Strategy: A 2024 Review

Updated Category News Views 111

Vinpai dropped its half-year numbers for 2024, and let me tell ya, it’s a mixed bag of good and bad. Sure, they reported a nice jump in sales—28% year-over-year to €5,111k—but you gotta dig deeper to see the cracks forming underneath that shiny surface. Revenue Growth vs. Margin Squeeze: What's the Real Deal? The revenue growth? That’s the feel-good story...

Continue Reading